Z-338 + Placebo
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Functional Dyspepsia
Conditions
Functional Dyspepsia
Trial Timeline
Sep 1, 2008 → Aug 1, 2010
NCT ID
NCT00761358About Z-338 + Placebo
Z-338 + Placebo is a phase 3 stage product being developed by Zeria Pharmaceutical for Functional Dyspepsia. The current trial status is completed. This product is registered under clinical trial identifier NCT00761358. Target conditions include Functional Dyspepsia.
What happened to similar drugs?
0 of 5 similar drugs in Functional Dyspepsia were approved
Approved (0) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00761358 | Phase 3 | Completed |
Competing Products
20 competing products in Functional Dyspepsia